Search - tctmd.com

Displaying 61 - 80 of 112

Sort: Relevancy | Date

Presentation

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll,

October 06, 2017

Presentation CDM 2017

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll

October 06, 2017

News Daily News

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Shelley Wood

June 05, 2017

News Conference News EuroPCR 2017

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Michael O'Riordan

May 26, 2017

News Daily News

Plaque Protrusion an Infrequent but Troubling Complication of Carotid Artery Stenting

L.A. McKeown

April 19, 2017

News Conference News ISC 2017

Does It Matter How Clot Is Removed in Acute Ischemic Stroke? Maybe Not

Todd Neale

February 22, 2017

Presentation JIM 2017

Complete Cerebral Embolic Protection Utilizing TriGuard™

Presenter: Azeem Latib

February 10, 2017

News Daily News

Carotid Stenting Outcomes Not Linked to Hospital Case Volume in German Registry

L.A. McKeown

November 18, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

News Daily News

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Michael O'Riordan

October 07, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Daily News

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Shelley Wood

September 13, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

Presentation EuroPCR 2016

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Presenter: Alexandra Lansky

May 20, 2016

News Daily News

Hospital Admissions for Acute Ischemic Stroke Down, Though Variation Exists Among Subgroups

Yael L. Maxwell

May 11, 2016

News Industry News

Silk Road Medical Announces CE Mark Approval and First Patients Treated with the Next Generation ENROUTE® Transcarotid Neuroprotection System

March 16, 2016

News Daily News

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Michael O'Riordan

March 14, 2016

News Daily News

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Michael O'Riordan

March 14, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

Advertisement

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Plaque Protrusion an Infrequent but Troubling Complication of Carotid Artery Stenting

Does It Matter How Clot Is Removed in Acute Ischemic Stroke? Maybe Not

Complete Cerebral Embolic Protection Utilizing TriGuard™

Carotid Stenting Outcomes Not Linked to Hospital Case Volume in German Registry

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Hospital Admissions for Acute Ischemic Stroke Down, Though Variation Exists Among Subgroups

Silk Road Medical Announces CE Mark Approval and First Patients Treated with the Next Generation ENROUTE® Transcarotid Neuroprotection System

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content